Colorectal cancer statistics, 2014
- PMID: 24639052
- DOI: 10.3322/caac.21220
Colorectal cancer statistics, 2014
Abstract
Colorectal cancer is the third most common cancer and the third leading cause of cancer death in men and women in the United States. This article provides an overview of colorectal cancer statistics, including the most current data on incidence, survival, and mortality rates and trends. Incidence data were provided by the National Cancer Institute's Surveillance, Epidemiology, and End Results program and the North American Association of Central Cancer Registries. Mortality data were provided by the National Center for Health Statistics. In 2014, an estimated 71,830 men and 65,000 women will be diagnosed with colorectal cancer and 26,270 men and 24,040 women will die of the disease. Greater than one-third of all deaths (29% in men and 43% in women) will occur in individuals aged 80 years and older. There is substantial variation in tumor location by age. For example, 26% of colorectal cancers in women aged younger than 50 years occur in the proximal colon, compared with 56% of cases in women aged 80 years and older. Incidence and death rates are highest in blacks and lowest in Asians/Pacific Islanders; among males during 2006 through 2010, death rates in blacks (29.4 per 100,000 population) were more than double those in Asians/Pacific Islanders (13.1) and 50% higher than those in non-Hispanic whites (19.2). Overall, incidence rates decreased by approximately 3% per year during the past decade (2001-2010). Notably, the largest drops occurred in adults aged 65 and older. For instance, rates for tumors located in the distal colon decreased by more than 5% per year. In contrast, rates increased during this time period among adults younger than 50 years. Colorectal cancer death rates declined by approximately 2% per year during the 1990s and by approximately 3% per year during the past decade. Progress in reducing colorectal cancer death rates can be accelerated by improving access to and use of screening and standard treatment in all populations.
Keywords: colon and rectum neoplasms; epidemiology; health disparities; screening and early detection.
© 2014 American Cancer Society, Inc.
Comment in
-
US colon cancer rate dropped 30% among over 50s in past decade.BMJ. 2014 Mar 18;348:g2226. doi: 10.1136/bmj.g2226. BMJ. 2014. PMID: 24642947 No abstract available.
Similar articles
-
Colorectal cancer statistics, 2017.CA Cancer J Clin. 2017 May 6;67(3):177-193. doi: 10.3322/caac.21395. Epub 2017 Mar 1. CA Cancer J Clin. 2017. PMID: 28248415
-
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.Cancer. 2018 Jul 1;124(13):2785-2800. doi: 10.1002/cncr.31551. Epub 2018 May 22. Cancer. 2018. PMID: 29786848 Free PMC article.
-
Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.Cancer. 2009 May 1;115(9):1967-76. doi: 10.1002/cncr.24216. Cancer. 2009. PMID: 19235249
-
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
-
Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality.Cancer. 1993 Jan 15;71(2 Suppl):517-23. doi: 10.1002/cncr.2820710205. Cancer. 1993. PMID: 8420671 Review.
Cited by
-
The gut microbiota and gastrointestinal surgery.Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):43-54. doi: 10.1038/nrgastro.2016.139. Epub 2016 Oct 12. Nat Rev Gastroenterol Hepatol. 2017. PMID: 27729657 Review.
-
Expression of MCRS1 and MCRS2 and their correlation with serum carcinoembryonic antigen in colorectal cancer.Exp Ther Med. 2016 Aug;12(2):589-596. doi: 10.3892/etm.2016.3424. Epub 2016 Jun 3. Exp Ther Med. 2016. PMID: 27446248 Free PMC article.
-
Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.Tumour Biol. 2015 Nov;36(11):8531-5. doi: 10.1007/s13277-015-3588-7. Epub 2015 Jun 2. Tumour Biol. 2015. PMID: 26032091
-
Ginsenosides: Allies of gastrointestinal tumor immunotherapy.Front Pharmacol. 2022 Oct 31;13:922029. doi: 10.3389/fphar.2022.922029. eCollection 2022. Front Pharmacol. 2022. PMID: 36386161 Free PMC article. Review.
-
Colorectal Cancer Screening Preferences among Black and Latino Primary Care Patients.J Immigr Minor Health. 2017 Oct;19(5):1100-1108. doi: 10.1007/s10903-016-0453-8. J Immigr Minor Health. 2017. PMID: 27351895 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous